Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 -2.64%55 PB Ratio is 11.96 as of Jul. 16, 2026, which is 20% above its 10-year median of 9.99. GuruFocus rates ROCO:6734 with a GF Score™ of 55/100 and a GF Value™ of NT$5.78 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 787 Medical Devices & Instruments companies, iXensor Co ranks worse than 93.52% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-16), iXensor Co's share price is NT$6.65. iXensor Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$0.56. Hence, iXensor Co's PB Ratio of today is 11.96.
The historical rank and industry rank for iXensor Co's PB Ratio or its related term are showing as below:
ROCO:6734'
s PB Ratio Range Over the Past 10 Years
Min: 2.68 Med: 9.99 Max: 28.7
Current: 11.96
During the past 10 years, iXensor Co's highest PB Ratio was 28.70. The lowest was 2.68. And the median was 9.99.
ROCO:6734's PB Ratio is ranked worse than 93.52% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs ROCO:6734: 11.96
During the past 12 months, iXensor Co's average Book Value Per Share Growth Rate was 85.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -45.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -37.90% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of iXensor Co was -19.00% per year. The lowest was -50.60% per year. And the median was -33.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
iXensor Co PB Ratio Related Terms
iXensor Co PB Ratio Historical Data
* Premium members only.
The historical data trend for iXensor Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, iXensor Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where iXensor Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
iXensor Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
iXensor Co (ROCO:6734) has a PB Ratio of 11.96 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on iXensor Co and its competitors. This is 20% above median its historical median of 9.99. Over the past decade, iXensor Co's PB Ratio has ranged from 2.68 to 28.70. According to the industry distribution chart, iXensor Co ranks #736 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 93.5%.
Is iXensor Co's PB Ratio too high?
iXensor Co's current PB Ratio of 11.96 is 20% above median its 10-year median of 9.99. Over the past 10 years, this metric has ranged from a low of 2.68 to a high of 28.70. The Medical Devices & Instruments industry median PB Ratio is 2.05. iXensor Co's value of 11.96 is 483.4% above this industry median. Based on the distribution chart, iXensor Co ranks #736 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iXensor Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #736 out of 787 companies for PB Ratio. This places iXensor Co in the lower half of its industry. The industry median PB Ratio is 2.05. iXensor Co's value of 11.96 is 483.4% above this benchmark. Historically, iXensor Co's own PB Ratio has ranged from 2.68 to 28.70 over the past decade. While the company's 10-year median is 9.99 vs. the industry median of 2.05, iXensor Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iXensor Co's current PB Ratio of 11.96 is 483.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on iXensor Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current PB Ratio is 11.96, which is 20% above median its own 10-year median of 9.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.78, compared to a current price of NT$6.65 — trading 15.1% above its estimated fair value. The current PB Ratio is 11.96, which is 20% above median its 10-year median of 9.99 and 483.4% above the Medical Devices & Instruments industry median of 2.05. iXensor Co's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current PB Ratio is 11.96 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued.
The current stock price of NT$6.65 is trading 15.1% above its estimated GF Value™ of NT$5.78.
GuruFocus considers iXensor Co to be Modestly Overvalued.
Key valuation signals for ROCO:6734:
PB Ratio: 11.96 (20% above median its 10-year median of 9.99)
GF Value™: NT$5.78 vs. price of NT$6.65 (15.1% above fair value)
Industry Position: 483.4% above the Medical Devices & Instruments median (#736 of 787)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
55GF Score
Get the complete analysis for ROCO:6734
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
